Androstenediol, a naturally occurring steroid and immune-modulating compound, was studied in the 1980s and became the focus of research for its potential therapeutic uses in the late 1990s. Its history is marked by its investigation for boosting immune function, but also by careful scrutiny due to hormonal activity that could cause side effects, leading to cautious dosing and monitoring in clinical studies. Androstenediol, a precursor to testosterone and estrogen with immunomodulatory properties, has been explored in various experimental therapies and is included in some investigational treatment regimens. Its development featured early-phase clinical trials and notable expanded access programs (EAPs) that allowed researchers to monitor effects and safety before broader use.
Brand Names
Bisexovis – androstenediol dipropionate
Bisexovister – androstenediol dipropionate
Ginandrin – androstenediol dipropionate
Stenandiol – androstenediol dipropionate
Mechanism of Action
Androstenediol is a naturally occurring steroid and intermediate in the biosynthesis of testosterone and estrogens. It exerts immunomodulatory effects by enhancing the proliferation and function of immune cells, particularly T lymphocytes and natural killer (NK) cells, and may increase the production of cytokines that support immune responses. Unlike pharmaceutical antiretrovirals, it does not directly inhibit viral replication; instead, it modulates the host immune system, potentially improving the body’s ability to respond to infections or hormonal imbalances.
PHARMACOKINETICS
Absorption
Androstenediol is absorbed through the gastrointestinal tract when taken orally, though its bioavailability is moderate due to first-pass metabolism in the liver. Absorption may be improved when taken with dietary fats or via alternative routes such as transdermal delivery.
Distribution
After absorption, androstenediol is distributed throughout the body, primarily binding to plasma proteins such as albumin and sex hormone–binding globulin (SHBG). It can cross cell membranes and enter tissues, including muscle, liver, and immune organs, where it can be converted into active androgens or estrogens. Tissue distribution depends on metabolism, binding affinities, and local enzymatic activity.
Metabolism
Androstenediol is metabolized primarily in the liver through enzymatic pathways that convert it into testosterone, dihydrotestosterone (DHT), and estrogens. It undergoesphase I oxidation/reduction reactions and phase II conjugation (glucuronidation and sulfation), which increase its water solubility for renal or biliary excretion. Metabolic rate can vary based on enzyme activity and individual hormonal status.
Elimination
Androstenediol and its metabolites are primarily excreted through the urine as conjugated glucuronides and sulfates. A smaller portion may be eliminated via bile and feces. The rate of elimination depends on metabolic conversion and kidney function, with most of the compound cleared within hours to days after administration.
Pharmacodynamics
Androstenediol acts as a prohormone and immunomodulator, influencing both hormonal and immune pathways. It can be converted into testosterone, dihydrotestosterone (DHT), and estrogens, exerting androgenic and estrogenic effects on target tissues. Additionally, it enhances T-cell and natural killer (NK) cell activity, stimulates cytokine production, and may support overall immune function. Its effects are dose-dependent and influenced by individual enzymatic activity and hormonal status.
Administration
Androstenediol can be administered orally, sublingually, or transdermally. Oral administration is common but subject to first-pass liver metabolism, which can reduce bioavailability. Transdermal or sublingual routes may improve systemic absorption and bypass some hepatic metabolism. Dosing is typically research-based or experimental, as androstenediol is not an FDA-approved prescription drug.
Dosage and strength
Androstenediol does not have officially approved dosing. In research or supplement use, it is typically administered in moderate amounts, with strength varying by formulation (oral tablets, capsules, or topical preparations). Exact dosing depends on the study protocol or intended effect.
Drug Interactions
Androstenediol may interact with otherhormonal or steroid medications, potentially changing their effects. It can also affect drugs metabolized in the liver (CYP450 enzymes). Caution is advised when taken with anticoagulants, corticosteroids, or other immune-related drugs.
Food Interactions
Androstenediol absorption may be influenced by food intake. Taking it with high-fat meals can enhance absorption, while fasting may reduce bioavailability. There are no well-documented interactions with specific foods, but consistent administration with or without meals is recommended for predictable effects.
Contraindications
Androstenediol should be avoided in individuals with hormone-sensitive cancers, severe liver disease, pregnancy, breastfeeding, or known hypersensitivity to the compound. Caution is advised in patients with cardiovascular, kidney, or endocrine disorders.
Side Effects
Androstenediol may cause hormonal and metabolic effects, including acne, oily skin, hair loss, mood changes, and changes in libido. It can also lead to liver enzyme alterations, fluid retention, and changes in cholesterol levels. In some cases, excessive use may disrupt natural hormone balance and menstrual cycles in women or cause testicular atrophy in men.
Toxicity
Androstenediol is generally considered low in acute toxicity, but high or prolonged doses can lead to hormonal imbalances, liver stress, and cardiovascular effects. Overuse may cause liver enzyme elevations, cholesterol changes, and reproductive system alterations. Toxic effects are mainly related to excessive androgenic or estrogenic activity rather than direct organ poisoning.
